Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
From Benzinga
Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022
From CNBC.com News
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
From Benzinga
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
From Benzinga
Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
December 17, 2021
Tickers
ALZN
From Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
Tickers
BIIB
From Benzinga
From Benzinga
Waiting to talk finance with an aging parent in cognitive decline is a mistake, experts say
November 30, 2021
From CNBC.com News
European Regulator Votes Down Biogen's Alzheimer's Drug
November 17, 2021
Tickers
BIIB
From Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
From Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
November 11, 2021
From Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
From Benzinga
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
From Benzinga
A Harvard nutritional psychiatrist shares the 5 foods she eats to sharpen brain health, memory and focus
October 08, 2021
From CNBC.com News
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
September 28, 2021
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
September 23, 2021
Tickers
BIIB
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.